Related Experiment Videos
Biodegradable poly (lactic acid) microspheres for drug delivery systems
1Institute for Frontier Medical Sciences, Kyoto University, Japan. biogen@frontier.kyoto-u.ac.jp
Yonsei Medical Journal
|February 24, 2001
Summary
New biodegradable microspheres using poly (lactic acid) (PLA) and poly (lactic-co-glycolic acid) (PLGA) offer controlled drug release. These systems maximize drug bioavailability while minimizing side effects compared to conventional methods.
Area of Science:
- Biomaterials Science
- Pharmaceutical Sciences
- Polymer Chemistry
Background:
- Conventional drug delivery systems (DDS) often face challenges in maximizing bioavailability and minimizing side effects.
- Biodegradable polymers, such as poly (lactic acid) (PLA) and poly (glycolic acid) (PGA), and their copolymers (PLGA), are increasingly explored for advanced DDS.
- Controlled or sustained drug release is a key strategy to improve therapeutic outcomes.
Purpose of the Study:
- To review the development and application of biodegradable microspheres for drug delivery.
- To evaluate the potential of PLA and PLGA-based microspheres for controlled and sustained drug release.
- To highlight the advantages of these novel DDS over conventional dosage forms.
Main Methods:
- Utilizing biodegradable polymers, specifically poly (lactic acid) (PLA) and poly (lactic-co-glycolic acid) (PLGA).
- Fabricating microcapsules and microspheres for the controlled release of bio-active agents.
- Reviewing a collaborative work program focused on DDS using these biodegradable microspheres.
Main Results:
- Biodegradable microspheres made from PLA and PLGA enable controlled and sustained drug release.
- These injectable microspheres offer pre-programmed durations of action.
- The use of these advanced DDS can lead to improved drug bioavailability and reduced side effects.
Conclusions:
- Biodegradable microspheres based on PLA and PLGA represent a promising approach for advanced drug delivery systems.
- These systems offer significant advantages over conventional drug formulations.
- Further development in this area holds potential for enhanced patient therapy.